Olink® to Science
The Olink to Science blog aims to inform, inspire, and support you in all things proteomics. Subscribe to stay updated on the latest proteomics research, ideas, and technological developments.
Latest blog posts
Dr. Krolewski and his team at the Harvard Medical School found 56 proteins to be significant in diabetic kidney disease patients. Potentially, these could serve as prognostic biomarkers for disease progression and treatment response. This is how adding proteomics to the methodologies elevated their research.
High-throughput multiplexed proteomic technology is leading the way to the latest developments in pre-clinical disease analysis in drug discovery. The pharmaceutical industry is now increasing its efforts in the discovery of novel drug targets by using protein quantitative trait loci (pQTLs), which allows for a more confident inference of disease causality and associated protein regulation.
An earlier Olink to Science blog post covered some amazing research that found that certain blood protein biomarkers have the potential to predict cancer up to 3 years before diagnosis. This may also be the case for lung cancer, as detailed in a recent study by Dagnino and her colleagues, where elevated levels of CDCP1 were detected in participants of a cohort who later developed the disease.
The following study illustrates how transcriptomics and proteomics complement one another to clarify the pathology of a complex, and little understood disease. Atopic dermatitis (AD) is the most common chronic skin condition affecting up to 20% of children and 7-10% of adults, depending on the population.
Want to learn more?
Here you will find the latest list of publications that have used Olink’s panels for protein biomarker discovery in the reported studies, or which have reviewed our technology. The publications are grouped according to year of publications.
With our in-house experts, digital tools and technical document library, we support you throughout the whole process of running your project, from study design to data interpretation.
Throughout pharmaceutical development and academic/clinical research, Olink provides actionable insights through protein biomarkers across an extensive range of application areas, covering all aspects of human biology in health and disease.
Protein data points generated
Publications listed on website